Belite Bio, Inc. Sponsored ADR (BLTE) vs Spyre Therapeutics, Inc. (SYRE)
Belite Bio, Inc. Sponsored ADR and Spyre Therapeutics, Inc. are both Biotechnology companies. Spyre Therapeutics, Inc. is the larger, with a market value of $7.7B against $6.8B — 1.1× the size. Across the 9 metrics below, Spyre Therapeutics, Inc. leads on 5 and Belite Bio, Inc. Sponsored ADR on 4.
Valuation
Profitability
| Metric | BLTE | SYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (28.52%) | (57.72%) |
| Return on assets | (21.60%) | (20.90%) | (49.22%) |
| Return on invested capital | (9.55%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack